Altre lingue Azenta, Inc.

Azioni

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 19/04/2024			Variaz. 5gg	Var. 1 gen.
50,65 ^USD	+0,32%		-7,49%	-22,24%

08/04	Transcript : Azenta, Inc. Presents at 23rd Annual Needham Virtual Healthcare Conference, Apr-08-2024 12:45 PM
04/04	AZENTA, INC. : rating Neutral da Evercore ISI	ZM

Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report	01/04
Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference	01/04
Azenta : 2023 Environmental, Social, and Governance (ESG) Report	29/03
Azenta Seeks Tuck-In M&A	19/03
Nvidia's dizzying rally spurs rush into AI-themed ETFs	19/03
Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum	12/03
Azenta's Fiscal Q1 Non-GAAP Earnings, Revenue Decline	08/02
Brooks: Fiscal Q1 Earnings Snapshot	07/02
Azenta, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	07/02
Earnings Flash (AZTA) AZENTA Posts Q1 EPS $0.02, vs. Street Est of $-0.03	07/02
Earnings Flash (AZTA) AZENTA Reports Q1 Revenue $154.3M, vs. Street Est of $151.2M	07/02
Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023	07/02
Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management	02/02
Azenta, Inc. Announces the Launch of the BioArc Ultra	02/02
Azenta, Inc. Announces Election of Directors	01/02
Azenta Announces Fiscal 2024 First Quarter Earnings Conference Call and Webcast	25/01
Azenta, Inc. Provides Earnings Guidance for the Fiscal Year 2024	18/01
Ellen M. Zane Decides Not to Stand for Election to the Board of Directors of Azenta, Inc	17/01
Azenta to Host Investor Day on March 14, 2024	11/01
Tranche Update on Azenta, Inc.'s Equity Buyback Plan announced on November 14, 2022.	11/01

Non ci sono risultati per questa ricerca